Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients

L. Demey (BRUXELLES, Belgium)

Source: International Congress 2017 – Biomarker-based asthma control
Session: Biomarker-based asthma control
Session type: Thematic Poster
Number: 3982
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Demey (BRUXELLES, Belgium). Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients. 3982

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effects of capsaicin on airway inflammation in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 586s
Year: 2004

Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004

Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006

Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Evaluation of the acute bronchodilator effect of beclomethasone/formoterol fixed combination on central and peripheral airway dimensions in asthmatic patients
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009


Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 135s
Year: 2005

Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Protective effect of inhaled iloprost on specific bronchial challenge in aspirin-sensitive asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 471s
Year: 2002

Effects of regular formoterol treatment on airway hyperresponsiveness in patients with mild to moderate asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 285s
Year: 2003

Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD
Source: Eur Respir J 2003 Dec 01;22(6):926-930
Year: 2003



Effect of treatment with positive airway pressure in bronchial hyper responsiveness in asthmatic children and adolescents.
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017


Influence of formoterol alone and its fixed combination with budesonide on airway responsiveness and airway inflammation induced by repeated low dose allergen challenge
Source: Eur Respir J 2007; 30: Suppl. 51, 749s
Year: 2007

Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy
Source: Annual Congress 2006 - New developments in the treatment and management of asthma
Year: 2006


IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003

Combined treatment with fluticasone plus salmeterol protects against allergen induced asthmatic responses and subsequent increase in sputum eosinophils
Source: Eur Respir J 2002; 20: Suppl. 38, 189s
Year: 2002

Effect of bronchial neutrophilia on airway remodeling in asthma
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


Effects of corticosteroids on airway inflammation in cough variant asthma
Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring
Year: 2004